knowledge -WSS

knowledge

author：knowledge 2025-10-02 11:08:24 - browse：99585

Photo illustration of Chris Viehbacher -- biotech coverage from STAT — Chris Viehbacher took over as Biogen CEO in November. Suzanne Kreiter/Globe staff; Photo illustration Alex Hogan/STAT

This was supposed to be the new Biogen. When Chris Viehbacher, a respected pharmaceutical executive, took over as CEO in November, Wall Street saw him as a steadying force for the wayward company and a strong personality who would stand up to its quarrelsome board.

Instead, Biogen’s board has saddled Viehbacher with the first crisis of his tenure at the company. Alex Denner, a long-time director, nominated a biotech executive who is also the mother of his child to succeed him on the board, and Biogen chose not to disclose the couple’s relationship to shareholders, an omission that shocked people close to the company and undermined the notion that Biogen was changing for the better.

“It’s just disappointing to see after all the criticism that has been levied at the company over the last few years, there really seems to be no self-awareness going into this recommendation,” said Brian Skorney, a securities analyst at Baird who covers Biogen.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： A letter from the executive editor: The 2023 STATUS List

WSS

Trump’s hydroxychloroquine hype: a risk to my treatment and to him

Helping hospitals and community health centers plan for resilience

What affirmative action's end means to a medical student

Lupron, used to halt puberty in children, may cause lasting health problems

With measles on the rise, a personal story of a devastating disease

Glen Campbell's doctor discusses his public struggle with Alzheimer's

Wikipedia

knowledge

knowledge

Peter Hotez and the public health issue of online harassment

Crowdfunding for unproven stem cell procedures spreads misinformation

ChatGPT in medicine: STAT answers readers' burning questions

Big Tobacco's 'harm reduction': Is it for real, or a sham?

New air purifier tech could be key to improving indoor air quality

Wearables generate powerful data but its not useful to doctors, yet

New air purifier tech could be key to improving indoor air quality

'Screen and refer' systems are hurting patients

Virginia high school admissions case could be legal follow

Security flaws in third

leisure time

AstraZeneca lung cancer study comes in below expectations

Solving academic medical centers' existential crisis

How a billionaire couple greased the skids for Pelosi’s drug pricing bill

Arc Institute generative AI designs new CRISPR systems

A letter from the executive editor: The 2023 STATUS List

Military medical care influenced by rank and race, new study finds

hotspot

knowledge

leisure time

knowledge